Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Panbela Therapeutics Q4 EPS $(0.26) Misses $(0.18) Estimate

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 188.89 percent decrease over losses of $(0.09) per

byBenzinga Newsdesk

March 24, 2022

1 minute read

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 44.44 percent. This is a 188.89 percent decrease over losses of $(0.09) per share from the same period last year.